NCT05966961View on ClinicalTrials.gov

Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery

RecruitingOBSERVATIONAL
Enrollment

2,998

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

August 31, 2028

Conditions
Surgical Site Infection
Interventions
DEVICE

Novosyn® in emergency or elective laparotomy or laparoscopic surgery

Fascia closure (and subcutaneous closure if applicable) after emergency or elective laparotomy or laparoscopic surgery.

DEVICE

Polyglactin 910 in emergency or elective laparotomy or laparoscopic surgery

Fascia closure (and subcutaneous closure if applicable) after emergency or elective laparotomy or laparoscopic surgery.

Trial Locations (4)

Unknown

RECRUITING

Pineta Grande Hospital, Napoli

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Universitario de Canarias, Santa Cruz de Tenerife

RECRUITING

Hospital Universitario Virgen del Rocío, Seville

Sponsors

Collaborators (1)

B.Braun Surgical SA
All Listed Sponsors
collaborator

B.Braun Surgical SA

INDUSTRY

lead

Aesculap AG

INDUSTRY